Cargando…

Advanced Glycation End Products and Psoriasis

Advanced glycation end products (AGEs) are biologically active compounds formed physiologically throughout a sequence of chemical reactions, to generate highly oxidant-reactive aldehydes that combine covalently to proteins. They accumulate slowly in tissues during ageing but also in metabolic and se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maurelli, Martina, Gisondi, Paolo, Girolomoni, Giampiero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056603/ https://www.ncbi.nlm.nih.gov/pubmed/36992201 http://dx.doi.org/10.3390/vaccines11030617

Ejemplares similares

Advanced Glycation End Products in the Pathogenesis of Psoriasis
por: Papagrigoraki, Anastasia, et al.
Publicado: (2017)

Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2022)

Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
por: Bellinato, Francesco, et al.
Publicado: (2022)

Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules
por: Bellinato, Francesco, et al.
Publicado: (2021)

Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2016)

Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines
por: Bellinato, Francesco, et al.
Publicado: (2021)

Annually Recurring Erythema Annulare Centrifugum: A New Case Series with Review of the Literature
por: Maurelli, Martina, et al.
Publicado: (2021)

Uncommon Non-Infectious Annular Dermatoses
por: Maurelli, Martina, et al.
Publicado: (2022)

Treatment Approaches to Moderate to Severe Psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2017)

Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks
por: Gisondi, Paolo, et al.
Publicado: (2020)

Glomerular filtration rate in patients with psoriasis treated with etanercept
por: Gisondi, Paolo, et al.
Publicado: (2016)

Efficacy and Safety of Secukinumab in Chronic Plaque Psoriasis and Psoriatic Arthritis Therapy
por: Gisondi, Paolo, et al.
Publicado: (2014)

Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies
por: Chiricozzi, Andrea, et al.
Publicado: (2020)

Pruritus as a Distinctive Feature of Type 2 Inflammation
por: Garcovich, Simone, et al.
Publicado: (2021)

The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments
por: Gisondi, Paolo, et al.
Publicado: (2020)

Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature
por: Bellinato, Francesco, et al.
Publicado: (2021)

Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study
por: Gisondi, Paolo, et al.
Publicado: (2022)

Increased red blood cell distribution width in patients with plaque psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2021)

Central Pain Sensitization in Patients with Chronic Plaque Psoriasis
por: Bellinato, Francesco, et al.
Publicado: (2023)

Management of Moderate to Severe Psoriasis in Patients with Metabolic Comorbidities
por: Gisondi, Paolo, et al.
Publicado: (2015)

The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis
por: Albanesi, Cristina, et al.
Publicado: (2018)

Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities
por: Gisondi, Paolo, et al.
Publicado: (2020)

Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis
por: Maurelli, Martina, et al.
Publicado: (2023)

Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease
por: Gisondi, Paolo, et al.
Publicado: (2022)

Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review
por: Girolomoni, Giampiero, et al.
Publicado: (2023)

Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2021)

Pharmacological Control of Receptor of Advanced Glycation End-Products and its Biological Effects in Psoriasis
por: Mezentsev, A. V., et al.
Publicado: (2013)

Targeting IL-4 for the Treatment of Atopic Dermatitis
por: Chiricozzi, Andrea, et al.
Publicado: (2020)

Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis
por: Bellinato, Francesco, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products on Dyslipidemia
por: Vekic, Jelena, et al.
Publicado: (2023)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Toxicity of advanced glycation end products (Review)
por: Kuzan, Aleksandra
Publicado: (2021)

Advanced Glycation End Products in Health and Disease
por: Reddy, V. Prakash, et al.
Publicado: (2022)

Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review
por: Dal Bello, Giacomo, et al.
Publicado: (2020)

Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
por: Gisondi, Paolo, et al.
Publicado: (2020)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Overview of Atopic Dermatitis in Different Ethnic Groups
por: Chiricozzi, Andrea, et al.
Publicado: (2023)

Advanced Glycation End-Products and Diabetic Neuropathy of the Retina
por: Oshitari, Toshiyuki
Publicado: (2023)

Advanced Glycation End-Products and Their Effects on Gut Health
por: Phuong-Nguyen, Kate, et al.
Publicado: (2023)

Advanced Glycation End-Products in Skeletal Muscle Aging
por: Olson, Lucas C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p7tolcip4pahflos9kd5f3nl9n